Benchmark Holdings has acquired the remaining 10.52% minority interest in its subsidiary Benchmark Genetics Iceland.

In December 2014, Benchmark acquired an 89.48% interest in Stofnfiskur, subsequently rebranding it Benchmark Genetics Iceland and merging it with its salmon genetics business in Norway. Since the acquisition, the business has grown substantially, benefiting from Benchmark's leading market position, investment and knowledge transfer within the group.

Enhanced by the recent construction of a new incubation center, Benchmark Genetics Iceland is core to the company's ability to supply highly specialized, biosecure salmon eggs to salmon producers in 35 countries around the world, year-round. Benchmark Genetics Iceland represents 50% of the group's salmon egg capacity.

“Benchmark's genetics operations in Iceland have a 200 million egg capacity and are core to our ability to supply highly biosecure salmon eggs year-round to customers around the world. The acquisition of the remaining minority interest is a natural step in delivering shareholder value through full ownership of the success of our genetics business,” said Trond Williksen, CEO of Benchmark Holdings.